# D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

> **NCT00827281** · PHASE2 · WITHDRAWN · sponsor: **Boston University Charles River Campus**

## Conditions studied

- Smokers

## Interventions

- **DRUG:** D-cycloserine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00827281
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2015-07-15
- **Final completion:** 2015-07-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not funded and pilot work proved impractical.
- **Last updated:** 2017-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827281, "D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00827281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*